EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

The CoMPaSS ‐ NMD Atlas Platform: A Secure Multimodal Infrastructure for Harmonized Data Collection, Exploration, and Future Artificial Intelligence–Driven Stratification in Hereditary Neuromuscular Disorders

R Corrias iD, P Foszner, A Nuredini iD, D Mendelsohn iD, A Töpf, J Díaz-Manera, M Obach iD, A Garzo iD, M Savarese iD, J Verdú-Díaz, S Pini iD, G La Vella and 17 more

European Journal of Neurology · 2026-11 · 33 (11)

DOI: 10.1111/ene.70804 ↗

At a glance

Journal article in European Journal of Neurology, published online on 2026-11-12. Written by R Corrias and 28 co-authors. Institution: FINCONS GROUP AG, Lugano, Switzerland. Major MEDLINE topics: Neuromuscular Diseases, Artificial Intelligence, Data Collection. 13 references. The full text is freely available (open access, CC BY 4.0). Funded by: HORIZON EUROPE Health.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Hereditary neuromuscular disorders exhibit marked phenotypic and molecular heterogeneity, which weakens genotype–phenotype correlation and complicates timely diagnosis, prognosis, and patient stratification for clinical trials. The Horizon Europe project CoMPaSS‐NMD aims to develop artificial‐intelligence‐based stratification tools by integrating clinical, genetic, histopathological, and imaging data from clinical reference centers across Europe and the United Kingdom.

Methods

We developed CoMPaSS‐NMD Atlas, a secure, modular web platform for pseudonymized data collection, multimodal data management, and controlled exploration. Clinical, technical, and data‐management experts defined requirements; contributing centers co‐designed electronic clinical and histopathology forms. Clinical phenotypes used the Human Phenotype Ontology (HPO), while imaging, histopathology, and sequencing data followed international standards.

Results

The platform supports role‐ and attribute‐based access, pseudonymized patient registration, metadata management, structured clinical data entry, MRI and histopathological uploads, and a dedicated genetic‐sequencing workflow. Cohort‐level exploration is driven by structured metadata and HPO terms, enabling hierarchical phenotype navigation, ontology‐aware data navigation, and cross‐domain queries spanning clinical, genetic, imaging, and histopathological features. Users can download raw files in their original formats, along with structured metadata reports in CSV or PDF, according to the permissions defined for data protection.

Conclusions

The Atlas provides a foundation for harmonized, standardized prospective data collection and for building large datasets for artificial intelligence‐ and machine learning‐based patient stratification. With secure governance, traceability, and multimodal integration, it is designed to support diagnostic and stratification research in hereditary neuromuscular disorders; clinical validation is ongoing.

Subjects

MeSH terms (MEDLINE)

Neuromuscular DiseasesArtificial IntelligenceData CollectionHumansEurope

Author keywords

artificial intelligencedata managementneuromuscular diseasesprecision medicinerare diseases

Authors and institutions

  • FINCONS GROUP AG, Lugano, Switzerland.
  • Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland.
  • Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Friedrich-Baur-Institute at the Department of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
  • John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University, and Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • TECNALIA, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, Gipuzkoa, Spain.

ORCID profiles: R Corrias, A Nuredini, D Mendelsohn, M Obach, A Garzo, M Savarese, S Pini, N Albano, L Piorecki, A Suwalska, M Marczyk, A DeAngelis, J Laporte, G Caudullo, V Straub, F M Santorelli, J Polanska, R Tupler, B Schoser

Funding

  • HORIZON EUROPE Health

Cite

APA

Corrias, R., Foszner, P., Nuredini, A., Mendelsohn, D., Töpf, A., Díaz-Manera, J., Obach, M., Garzo, A., Savarese, M., Verdú-Díaz, J., Pini, S., La Vella, G., Albano, N., Markiel, M., Piorecki, L., Suwalska, A., Socha, M., Marczyk, M., Bonelli, S., …, & Schoser, B. (2026). The CoMPaSS ‐ NMD Atlas Platform: A Secure Multimodal Infrastructure for Harmonized Data Collection, Exploration, and Future Artificial Intelligence–Driven Stratification in Hereditary Neuromuscular Disorders. European Journal of Neurology, 33(11). https://doi.org/10.1111/ene.70804

Vancouver

Corrias R, Foszner P, Nuredini A, Mendelsohn D, Töpf A, Díaz-Manera J, et al. The CoMPaSS ‐ NMD Atlas Platform: A Secure Multimodal Infrastructure for Harmonized Data Collection, Exploration, and Future Artificial Intelligence–Driven Stratification in Hereditary Neuromuscular Disorders. European Journal of Neurology. 2026;33(11). doi:10.1111/ene.70804

BibTeX
@article{Corrias2026,
  author = {Corrias, R and Foszner, P and Nuredini, A and Mendelsohn, D and Töpf, A and Díaz-Manera, J and Obach, M and Garzo, A and Savarese, M and Verdú-Díaz, J and Pini, S and La Vella, G and Albano, N and Markiel, M and Piorecki, L and Suwalska, A and Socha, M and Marczyk, M and Bonelli, S and DeAngelis, A and Laporte, J and Caudullo, G and Savino, E and Straub, V and Santorelli, F M and Polanska, J and Scipioni, M P and Tupler, R and Schoser, B},
  title = {The CoMPaSS ‐ NMD Atlas Platform: A Secure Multimodal Infrastructure for Harmonized Data Collection, Exploration, and Future Artificial Intelligence–Driven Stratification in Hereditary Neuromuscular Disorders},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {11},
  doi = {10.1111/ene.70804}
}
Start for free →